Medium-/Long-Term Effects of a Specific Exercise Protocol Combined with Patient Education on Spine Mobility, Chronic Fatigue, Pain, Aerobic Fitness and Level of Disability in Fibromyalgia

Table 3

Physiatrical evaluation results.

Measures	Groups	T0 (mean ± SD)	T1 (mean ± SD)	T6 (mean ± SD)	P (T0-T1)	P (T0–T6)
ROM (degrees)
Flexion	EG	37.75±14.30	43.95±11.26	45.40±9.53	ns	ns
	CG	35.33±15.69	34.00±10.61	32.67±11.77	ns	ns
Extension	EG	3.75±6.07	7.40±6.49	8.45±6.02	0.040	0.008
	CG	4.75±5.38	4.33±4.25	4.33±2.67	ns	ns
Inclination L	EG	22.00±7.31	27.60±6.97	28.80±8.48	0.014	0.003
	CG	22.42±8.39	22.42±4.85	22.42±4.70	ns	ns
Inclination R	EG	20.50±6.01	26.60±7.35	26.25±6.87	0.025	0.031
	CG	21.08±8.33	22.17±7.55	22.33±8.90	ns	ns
Rotation L	EG	39.75±12.93	47.00±8.11	52.75±12.91	0.045	0.004
	CG	39.83±12.81	39.83±9.68	40.75±9.81	ns	ns
Rotation R	EG	40.30±11.90	47.25±11.22	49.15±9.72	ns	0.041
	CG	41.25±14.25	39.08±10.45	42.33±9.85	ns	ns
6MWT (speed: m/s)	EG	1.05±0.19	1.30±0.24	1.24±0.22	<0.001	<0.001
	CG	1.12±0.24	1.13±0.24	1.03±0.21	ns	ns
HAQ (0–60)	EG	13.95±8.79	10.40±8.72	10.15±10.32	ns	ns
	CG	12.50±6.79	12.75±8.49	11.75±6.96	ns	ns
FSS (9–63)	EG	52.05±11.44	47.90±10.62	47.25±11.29	ns	ns
	CG	56.00±7.03	55.50±7.40	54.58±9.25	ns	ns

SD: standard deviation; ROM: range of motion; EG: experimental group; CG: control group; L: left; R: right; 6MWT: 6-minute walking test; HAQ: Health Assessment Questionnaire; FSS: fatigue severity scale; ns: nonsignificant.
In bold: statistically significant values.